US › Healthcare

China SXT Pharmaceuticals Inc (SXTC)

US · Healthcare · Drug Manufacturers - Specialty & Generic

$2.44+11.19%

Last close · 2026-09-17

Latest quarter · ended 2026-06-30

Revenue

$1.2M

Revenue YoY

+163.0%

Net profit

$163,718

EPS

$-0.05

EPS estimate

$0.00

Net margin

13.7%

Key statistics

Market cap

$3.1M

Forward P/E

0.0

P/B

0.12

Book value

$2,480.58

EPS (TTM)

$-648.02

52-week high

$311.68

52-week low

$0.04

50-day MA

$54.80

200-day MA

$2,889.43

Beta

1.84

Shareholding

Insiders

33.37%

Largest institutional holders

Fund	Stake
Sabby Management LLC	0.20%
Royal Bank of Canada	0.00%
Caitong International Asset Management Co., Limited.	0.00%
UBS Group AG	0.00%
Amvescap Plc.	0.00%
Geode Capital Management, LLC	0.00%
Tower Research Capital LLC	0.00%
Citadel Advisors Llc	0.00%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for China SXT Pharmaceuticals Inc — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc Merck & Company Inc UnitedHealth Group Incorporated Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Novo Nordisk A/S Gilead Sciences Inc Abbott Laboratories

Data updated 2026-09-18.